JP2020517261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517261A5 JP2020517261A5 JP2019556929A JP2019556929A JP2020517261A5 JP 2020517261 A5 JP2020517261 A5 JP 2020517261A5 JP 2019556929 A JP2019556929 A JP 2019556929A JP 2019556929 A JP2019556929 A JP 2019556929A JP 2020517261 A5 JP2020517261 A5 JP 2020517261A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- ifn
- cells
- mir
- cytokine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 146
- 102000014150 Interferons Human genes 0.000 claims description 108
- 108010050904 Interferons Proteins 0.000 claims description 108
- 229940079322 interferon Drugs 0.000 claims description 108
- 102000004127 Cytokines Human genes 0.000 claims description 62
- 108090000695 Cytokines Proteins 0.000 claims description 62
- 206010028980 Neoplasm Diseases 0.000 claims description 60
- 210000002540 macrophage Anatomy 0.000 claims description 51
- 210000001616 monocyte Anatomy 0.000 claims description 49
- 239000013598 vector Substances 0.000 claims description 45
- -1 efrine B2 Proteins 0.000 claims description 43
- 210000001185 bone marrow Anatomy 0.000 claims description 42
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 40
- 201000011510 cancer Diseases 0.000 claims description 38
- 210000000130 stem cell Anatomy 0.000 claims description 37
- 210000004027 cell Anatomy 0.000 claims description 36
- 108091028066 Mir-126 Proteins 0.000 claims description 32
- 239000000427 antigen Substances 0.000 claims description 29
- 102000036639 antigens Human genes 0.000 claims description 29
- 108091007433 antigens Proteins 0.000 claims description 29
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 28
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 28
- 239000002773 nucleotide Substances 0.000 claims description 28
- 125000003729 nucleotide group Chemical group 0.000 claims description 28
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims description 27
- 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 claims description 27
- 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 claims description 27
- 108091008874 T cell receptors Proteins 0.000 claims description 27
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 27
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims description 27
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 26
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 26
- 239000002243 precursor Substances 0.000 claims description 24
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 23
- 230000002265 prevention Effects 0.000 claims description 16
- 230000003394 haemopoietic effect Effects 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 15
- ZADWXFSZEAPBJS-JTQLQIEISA-N 1-methyl-L-tryptophan Chemical compound C1=CC=C2N(C)C=C(C[C@H](N)C(O)=O)C2=C1 ZADWXFSZEAPBJS-JTQLQIEISA-N 0.000 claims description 13
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 12
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 12
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 12
- 230000009261 transgenic effect Effects 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 claims description 8
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims description 8
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 claims description 8
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 8
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 8
- 102100024217 CAMPATH-1 antigen Human genes 0.000 claims description 8
- 102100032912 CD44 antigen Human genes 0.000 claims description 8
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims description 8
- 206010009944 Colon cancer Diseases 0.000 claims description 8
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims description 8
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 8
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 8
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 8
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 8
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims description 8
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 8
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims description 8
- 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 claims description 8
- 102100031413 L-dopachrome tautomerase Human genes 0.000 claims description 8
- 101710093778 L-dopachrome tautomerase Proteins 0.000 claims description 8
- 206010025323 Lymphomas Diseases 0.000 claims description 8
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims description 8
- 102000000440 Melanoma-associated antigen Human genes 0.000 claims description 8
- 102100034256 Mucin-1 Human genes 0.000 claims description 8
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 claims description 8
- 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 claims description 8
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 8
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000012737 microarray-based gene expression Methods 0.000 claims description 8
- 238000012243 multiplex automated genomic engineering Methods 0.000 claims description 8
- 210000001519 tissue Anatomy 0.000 claims description 8
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims description 7
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims description 7
- 206010060862 Prostate cancer Diseases 0.000 claims description 7
- 108010072866 Prostate-Specific Antigen Proteins 0.000 claims description 7
- 102100038358 Prostate-specific antigen Human genes 0.000 claims description 7
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 7
- 102000005962 receptors Human genes 0.000 claims description 7
- 108020003175 receptors Proteins 0.000 claims description 7
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 208000017604 Hodgkin disease Diseases 0.000 claims description 5
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims description 5
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims description 5
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims description 5
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 5
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims description 5
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 5
- 230000018044 dehydration Effects 0.000 claims description 5
- 238000006297 dehydration reaction Methods 0.000 claims description 5
- ZADWXFSZEAPBJS-UHFFFAOYSA-N racemic N-methyl tryptophan Natural products C1=CC=C2N(C)C=C(CC(N)C(O)=O)C2=C1 ZADWXFSZEAPBJS-UHFFFAOYSA-N 0.000 claims description 5
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 4
- WEYNBWVKOYCCQT-UHFFFAOYSA-N 1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea Chemical compound O1C(CN(C)C)=CC=C1CSCCNC(=O)NC1=CC=C(C)C(Cl)=C1 WEYNBWVKOYCCQT-UHFFFAOYSA-N 0.000 claims description 4
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 claims description 4
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims description 4
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims description 4
- 102100021305 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Human genes 0.000 claims description 4
- 101710137115 Adenylyl cyclase-associated protein 1 Proteins 0.000 claims description 4
- 201000003076 Angiosarcoma Diseases 0.000 claims description 4
- 101000719121 Arabidopsis thaliana Protein MEI2-like 1 Proteins 0.000 claims description 4
- 102100035526 B melanoma antigen 1 Human genes 0.000 claims description 4
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims description 4
- 206010006187 Breast cancer Diseases 0.000 claims description 4
- 208000026310 Breast neoplasm Diseases 0.000 claims description 4
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims description 4
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims description 4
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 4
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims description 4
- 101150013553 CD40 gene Proteins 0.000 claims description 4
- 108010065524 CD52 Antigen Proteins 0.000 claims description 4
- 241000282836 Camelus dromedarius Species 0.000 claims description 4
- 102100039510 Cancer/testis antigen 2 Human genes 0.000 claims description 4
- 102100026548 Caspase-8 Human genes 0.000 claims description 4
- 108090000538 Caspase-8 Proteins 0.000 claims description 4
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims description 4
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 4
- 101710178046 Chorismate synthase 1 Proteins 0.000 claims description 4
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims description 4
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 4
- 102100032768 Complement receptor type 2 Human genes 0.000 claims description 4
- 102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 claims description 4
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 claims description 4
- 101710152695 Cysteine synthase 1 Proteins 0.000 claims description 4
- 101100481408 Danio rerio tie2 gene Proteins 0.000 claims description 4
- 206010014733 Endometrial cancer Diseases 0.000 claims description 4
- 206010014759 Endometrial neoplasm Diseases 0.000 claims description 4
- 102100038083 Endosialin Human genes 0.000 claims description 4
- 101710144543 Endosialin Proteins 0.000 claims description 4
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims description 4
- 102100031940 Epithelial cell adhesion molecule Human genes 0.000 claims description 4
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims description 4
- 102100038595 Estrogen receptor Human genes 0.000 claims description 4
- 102100028043 Fibroblast growth factor 3 Human genes 0.000 claims description 4
- 102100028075 Fibroblast growth factor 6 Human genes 0.000 claims description 4
- 108090000382 Fibroblast growth factor 6 Proteins 0.000 claims description 4
- 102100037362 Fibronectin Human genes 0.000 claims description 4
- 108010067306 Fibronectins Proteins 0.000 claims description 4
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 claims description 4
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 claims description 4
- 108010001515 Galectin 4 Proteins 0.000 claims description 4
- 102000000805 Galectin 4 Human genes 0.000 claims description 4
- 101710121810 Galectin-9 Proteins 0.000 claims description 4
- 102100031351 Galectin-9 Human genes 0.000 claims description 4
- 208000032612 Glial tumor Diseases 0.000 claims description 4
- 206010018338 Glioma Diseases 0.000 claims description 4
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 4
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 claims description 4
- 102000006354 HLA-DR Antigens Human genes 0.000 claims description 4
- 108010058597 HLA-DR Antigens Proteins 0.000 claims description 4
- 208000001258 Hemangiosarcoma Diseases 0.000 claims description 4
- 102100021866 Hepatocyte growth factor Human genes 0.000 claims description 4
- 101000773083 Homo sapiens 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 claims description 4
- 101001042227 Homo sapiens Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Proteins 0.000 claims description 4
- 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 claims description 4
- 101000980814 Homo sapiens CAMPATH-1 antigen Proteins 0.000 claims description 4
- 101000889345 Homo sapiens Cancer/testis antigen 2 Proteins 0.000 claims description 4
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims description 4
- 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 claims description 4
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 claims description 4
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 claims description 4
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims description 4
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 claims description 4
- 101001046677 Homo sapiens Integrin alpha-V Proteins 0.000 claims description 4
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 4
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 4
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims description 4
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 claims description 4
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims description 4
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 claims description 4
- 101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 claims description 4
- 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 claims description 4
- 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 claims description 4
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 4
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims description 4
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims description 4
- 101001098352 Homo sapiens OX-2 membrane glycoprotein Proteins 0.000 claims description 4
- 101000874141 Homo sapiens Probable ATP-dependent RNA helicase DDX43 Proteins 0.000 claims description 4
- 101000880770 Homo sapiens Protein SSX2 Proteins 0.000 claims description 4
- 101000743264 Homo sapiens RNA-binding protein 6 Proteins 0.000 claims description 4
- 101001109419 Homo sapiens RNA-binding protein NOB1 Proteins 0.000 claims description 4
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 4
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 4
- 101000857677 Homo sapiens Runt-related transcription factor 1 Proteins 0.000 claims description 4
- 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 claims description 4
- 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 claims description 4
- 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 claims description 4
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 4
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims description 4
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 4
- 101000648075 Homo sapiens Trafficking protein particle complex subunit 1 Proteins 0.000 claims description 4
- 101000904724 Homo sapiens Transmembrane glycoprotein NMB Proteins 0.000 claims description 4
- 101000801433 Homo sapiens Trophoblast glycoprotein Proteins 0.000 claims description 4
- 101000610605 Homo sapiens Tumor necrosis factor receptor superfamily member 10A Proteins 0.000 claims description 4
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 4
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims description 4
- 102000038455 IGF Type 1 Receptor Human genes 0.000 claims description 4
- 101710123134 Ice-binding protein Proteins 0.000 claims description 4
- 101710082837 Ice-structuring protein Proteins 0.000 claims description 4
- 108010073816 IgE Receptors Proteins 0.000 claims description 4
- 102000009438 IgE Receptors Human genes 0.000 claims description 4
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims description 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 4
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims description 4
- 108050002021 Integrator complex subunit 2 Proteins 0.000 claims description 4
- 102100022337 Integrin alpha-V Human genes 0.000 claims description 4
- 108010042918 Integrin alpha5beta1 Proteins 0.000 claims description 4
- 108010047852 Integrin alphaVbeta3 Proteins 0.000 claims description 4
- 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 claims description 4
- 102000003816 Interleukin-13 Human genes 0.000 claims description 4
- 108090000176 Interleukin-13 Proteins 0.000 claims description 4
- 108010038453 Interleukin-2 Receptors Proteins 0.000 claims description 4
- 102000010789 Interleukin-2 Receptors Human genes 0.000 claims description 4
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims description 4
- 102000004889 Interleukin-6 Human genes 0.000 claims description 4
- 108090001005 Interleukin-6 Proteins 0.000 claims description 4
- 208000008839 Kidney Neoplasms Diseases 0.000 claims description 4
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims description 4
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 claims description 4
- 102100024640 Low-density lipoprotein receptor Human genes 0.000 claims description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 4
- 108010010995 MART-1 Antigen Proteins 0.000 claims description 4
- 108700018351 Major Histocompatibility Complex Proteins 0.000 claims description 4
- 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 claims description 4
- 102000003735 Mesothelin Human genes 0.000 claims description 4
- 108090000015 Mesothelin Proteins 0.000 claims description 4
- 108010006035 Metalloproteases Proteins 0.000 claims description 4
- 102000005741 Metalloproteases Human genes 0.000 claims description 4
- 102100023123 Mucin-16 Human genes 0.000 claims description 4
- 101100481410 Mus musculus Tek gene Proteins 0.000 claims description 4
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims description 4
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 4
- 102000003505 Myosin Human genes 0.000 claims description 4
- 108060008487 Myosin Proteins 0.000 claims description 4
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims description 4
- 206010029260 Neuroblastoma Diseases 0.000 claims description 4
- 102100037589 OX-2 membrane glycoprotein Human genes 0.000 claims description 4
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 4
- 108060006580 PRAME Proteins 0.000 claims description 4
- 102000036673 PRAME Human genes 0.000 claims description 4
- 102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 claims description 4
- 108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 claims description 4
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 4
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims description 4
- 102100035724 Probable ATP-dependent RNA helicase DDX43 Human genes 0.000 claims description 4
- 102100032831 Protein ITPRID2 Human genes 0.000 claims description 4
- 102100037686 Protein SSX2 Human genes 0.000 claims description 4
- 102000014128 RANK Ligand Human genes 0.000 claims description 4
- 108010025832 RANK Ligand Proteins 0.000 claims description 4
- 102100038150 RNA-binding protein 6 Human genes 0.000 claims description 4
- 102100022491 RNA-binding protein NOB1 Human genes 0.000 claims description 4
- 108091005682 Receptor kinases Proteins 0.000 claims description 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 4
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 4
- 206010038389 Renal cancer Diseases 0.000 claims description 4
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 claims description 4
- 102100029198 SLAM family member 7 Human genes 0.000 claims description 4
- 206010039491 Sarcoma Diseases 0.000 claims description 4
- 101710173693 Short transient receptor potential channel 1 Proteins 0.000 claims description 4
- 208000021712 Soft tissue sarcoma Diseases 0.000 claims description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 4
- 102100036234 Synaptonemal complex protein 1 Human genes 0.000 claims description 4
- 101710143177 Synaptonemal complex protein 1 Proteins 0.000 claims description 4
- 102100035721 Syndecan-1 Human genes 0.000 claims description 4
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 4
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims description 4
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 4
- 108700019889 TEL-AML1 fusion Proteins 0.000 claims description 4
- 102100033082 TNF receptor-associated factor 3 Human genes 0.000 claims description 4
- 101001051488 Takifugu rubripes Neural cell adhesion molecule L1 Proteins 0.000 claims description 4
- 208000024770 Thyroid neoplasm Diseases 0.000 claims description 4
- 102100025256 Trafficking protein particle complex subunit 1 Human genes 0.000 claims description 4
- 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 claims description 4
- 102100033579 Trophoblast glycoprotein Human genes 0.000 claims description 4
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 claims description 4
- 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 claims description 4
- 101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 claims description 4
- 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 claims description 4
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 4
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 4
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims description 4
- 102000003425 Tyrosinase Human genes 0.000 claims description 4
- 108060008724 Tyrosinase Proteins 0.000 claims description 4
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 4
- 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 claims description 4
- 108010053096 Vascular Endothelial Growth Factor Receptor-1 Proteins 0.000 claims description 4
- 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 claims description 4
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims description 4
- 108010065472 Vimentin Proteins 0.000 claims description 4
- 102000013127 Vimentin Human genes 0.000 claims description 4
- 208000009956 adenocarcinoma Diseases 0.000 claims description 4
- 229950001537 amatuximab Drugs 0.000 claims description 4
- 230000003302 anti-idiotype Effects 0.000 claims description 4
- 210000000013 bile duct Anatomy 0.000 claims description 4
- 201000009036 biliary tract cancer Diseases 0.000 claims description 4
- 208000020790 biliary tract neoplasm Diseases 0.000 claims description 4
- 201000010881 cervical cancer Diseases 0.000 claims description 4
- 208000029742 colonic neoplasm Diseases 0.000 claims description 4
- 229950010640 ensituximab Drugs 0.000 claims description 4
- 201000004101 esophageal cancer Diseases 0.000 claims description 4
- 108010038795 estrogen receptors Proteins 0.000 claims description 4
- 230000001605 fetal effect Effects 0.000 claims description 4
- 102000006815 folate receptor Human genes 0.000 claims description 4
- 108020005243 folate receptor Proteins 0.000 claims description 4
- 102000036215 folic acid binding proteins Human genes 0.000 claims description 4
- 108091011001 folic acid binding proteins Proteins 0.000 claims description 4
- 150000002270 gangliosides Chemical class 0.000 claims description 4
- 206010017758 gastric cancer Diseases 0.000 claims description 4
- 201000010536 head and neck cancer Diseases 0.000 claims description 4
- 208000014829 head and neck neoplasm Diseases 0.000 claims description 4
- 201000010982 kidney cancer Diseases 0.000 claims description 4
- 201000007270 liver cancer Diseases 0.000 claims description 4
- 208000014018 liver neoplasm Diseases 0.000 claims description 4
- 201000005202 lung cancer Diseases 0.000 claims description 4
- 208000020816 lung neoplasm Diseases 0.000 claims description 4
- 208000003747 lymphoid leukemia Diseases 0.000 claims description 4
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 4
- 201000001441 melanoma Diseases 0.000 claims description 4
- PUPNJSIFIXXJCH-UHFFFAOYSA-N n-(4-hydroxyphenyl)-2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetamide Chemical compound C1=CC(O)=CC=C1NC(=O)CN1S(=O)(=O)C2=CC=CC=C2C1=O PUPNJSIFIXXJCH-UHFFFAOYSA-N 0.000 claims description 4
- 201000008968 osteosarcoma Diseases 0.000 claims description 4
- 201000002528 pancreatic cancer Diseases 0.000 claims description 4
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 4
- 102000003998 progesterone receptors Human genes 0.000 claims description 4
- 108090000468 progesterone receptors Proteins 0.000 claims description 4
- 235000002020 sage Nutrition 0.000 claims description 4
- 201000011549 stomach cancer Diseases 0.000 claims description 4
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 claims description 4
- 208000011580 syndromic disease Diseases 0.000 claims description 4
- 101150047061 tag-72 gene Proteins 0.000 claims description 4
- 201000002510 thyroid cancer Diseases 0.000 claims description 4
- 210000005048 vimentin Anatomy 0.000 claims description 4
- 206010061692 Benign muscle neoplasm Diseases 0.000 claims description 3
- 102000008857 Ferritin Human genes 0.000 claims description 3
- 108050000784 Ferritin Proteins 0.000 claims description 3
- 238000008416 Ferritin Methods 0.000 claims description 3
- 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims description 3
- 108010075704 HLA-A Antigens Proteins 0.000 claims description 3
- 102100037931 Harmonin Human genes 0.000 claims description 3
- 101000805947 Homo sapiens Harmonin Proteins 0.000 claims description 3
- 208000034578 Multiple myelomas Diseases 0.000 claims description 3
- 201000004458 Myoma Diseases 0.000 claims description 3
- SUHQNCLNRUAGOO-UHFFFAOYSA-N N-glycoloyl-neuraminic acid Natural products OCC(O)C(O)C(O)C(NC(=O)CO)C(O)CC(=O)C(O)=O SUHQNCLNRUAGOO-UHFFFAOYSA-N 0.000 claims description 3
- FDJKUWYYUZCUJX-UHFFFAOYSA-N N-glycolyl-beta-neuraminic acid Natural products OCC(O)C(O)C1OC(O)(C(O)=O)CC(O)C1NC(=O)CO FDJKUWYYUZCUJX-UHFFFAOYSA-N 0.000 claims description 3
- FDJKUWYYUZCUJX-KVNVFURPSA-N N-glycolylneuraminic acid Chemical compound OC[C@H](O)[C@H](O)[C@@H]1O[C@](O)(C(O)=O)C[C@H](O)[C@H]1NC(=O)CO FDJKUWYYUZCUJX-KVNVFURPSA-N 0.000 claims description 3
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 3
- 206010033128 Ovarian cancer Diseases 0.000 claims description 3
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 3
- 102100035748 Squamous cell carcinoma antigen recognized by T-cells 3 Human genes 0.000 claims description 3
- 101710185775 Squamous cell carcinoma antigen recognized by T-cells 3 Proteins 0.000 claims description 3
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 3
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 3
- 108010026331 alpha-Fetoproteins Proteins 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 210000002950 fibroblast Anatomy 0.000 claims description 3
- 230000002608 insulinlike Effects 0.000 claims description 3
- 230000035755 proliferation Effects 0.000 claims description 3
- 206010042863 synovial sarcoma Diseases 0.000 claims description 3
- 208000037398 BCR-ABL1 negative atypical chronic myeloid leukemia Diseases 0.000 claims description 2
- NMABFUGAUQKBEM-LARVRRBISA-N CN1C=C(C[C@H](N)C(=O)O)C2=CC=CC=C12.CN1C=C(C[C@H](N)C(=O)O)C2=CC=CC=C12 Chemical compound CN1C=C(C[C@H](N)C(=O)O)C2=CC=CC=C12.CN1C=C(C[C@H](N)C(=O)O)C2=CC=CC=C12 NMABFUGAUQKBEM-LARVRRBISA-N 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 102000003846 Carbonic anhydrases Human genes 0.000 claims description 2
- 108090000209 Carbonic anhydrases Proteins 0.000 claims description 2
- 102000001301 EGF receptor Human genes 0.000 claims description 2
- 108060006698 EGF receptor Proteins 0.000 claims description 2
- 206010016654 Fibrosis Diseases 0.000 claims description 2
- 102000009465 Growth Factor Receptors Human genes 0.000 claims description 2
- 108010009202 Growth Factor Receptors Proteins 0.000 claims description 2
- 208000037379 Myeloid Chronic Atypical BCR-ABL Negative Leukemia Diseases 0.000 claims description 2
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 claims description 2
- 102100027244 U4/U6.U5 tri-snRNP-associated protein 1 Human genes 0.000 claims description 2
- 101710155955 U4/U6.U5 tri-snRNP-associated protein 1 Proteins 0.000 claims description 2
- 201000004892 atypical chronic myeloid leukemia Diseases 0.000 claims description 2
- 230000008472 epithelial growth Effects 0.000 claims description 2
- 230000004761 fibrosis Effects 0.000 claims description 2
- 230000002062 proliferating effect Effects 0.000 claims description 2
- 210000002307 prostate Anatomy 0.000 claims description 2
- 208000002250 Hematologic Neoplasms Diseases 0.000 claims 4
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims 3
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims 3
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 3
- 102000007471 Adenosine A2A receptor Human genes 0.000 claims 2
- 108010085277 Adenosine A2A receptor Proteins 0.000 claims 2
- 102100038078 CD276 antigen Human genes 0.000 claims 2
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 2
- 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 claims 2
- 102000002698 KIR Receptors Human genes 0.000 claims 2
- 108010043610 KIR Receptors Proteins 0.000 claims 2
- 102100020862 Lymphocyte activation gene 3 protein Human genes 0.000 claims 2
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims 2
- 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims 2
- 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims 2
- 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 claims 2
- 102000057288 Tryptophan 2,3-dioxygenases Human genes 0.000 claims 2
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims 2
- 102100038929 V-set domain-containing T-cell activation inhibitor 1 Human genes 0.000 claims 2
- 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 claims 2
- 102000006639 indoleamine 2,3-dioxygenase Human genes 0.000 claims 2
- 108020004201 indoleamine 2,3-dioxygenase Proteins 0.000 claims 2
- 101710144268 B- and T-lymphocyte attenuator Proteins 0.000 claims 1
- 102100028737 CAP-Gly domain-containing linker protein 1 Human genes 0.000 claims 1
- 101100476671 Caenorhabditis elegans sart-3 gene Proteins 0.000 claims 1
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 1
- 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims 1
- 101000954709 Homo sapiens Doublecortin domain-containing protein 2 Proteins 0.000 claims 1
- 101000985516 Homo sapiens Hermansky-Pudlak syndrome 5 protein Proteins 0.000 claims 1
- 101000614481 Homo sapiens Kidney-associated antigen 1 Proteins 0.000 claims 1
- 101000821981 Homo sapiens Sarcoma antigen 1 Proteins 0.000 claims 1
- 101000665137 Homo sapiens Scm-like with four MBT domains protein 1 Proteins 0.000 claims 1
- 101000955999 Homo sapiens V-set domain-containing T-cell activation inhibitor 1 Proteins 0.000 claims 1
- 108010031794 IGF Type 1 Receptor Proteins 0.000 claims 1
- 102000037982 Immune checkpoint proteins Human genes 0.000 claims 1
- 108091008036 Immune checkpoint proteins Proteins 0.000 claims 1
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 108010079206 V-Set Domain-Containing T-Cell Activation Inhibitor 1 Proteins 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 201000000053 blastoma Diseases 0.000 claims 1
- 108010038764 cytoplasmic linker protein 170 Proteins 0.000 claims 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 201000008184 embryoma Diseases 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 206010044412 transitional cell carcinoma Diseases 0.000 claims 1
- 210000003741 urothelium Anatomy 0.000 claims 1
- 230000002489 hematologic effect Effects 0.000 description 4
- 108010021064 CTLA-4 Antigen Proteins 0.000 description 2
- 229940045513 CTLA4 antagonist Drugs 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 102000006306 Antigen Receptors Human genes 0.000 description 1
- 108010083359 Antigen Receptors Proteins 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000005746 immune checkpoint blockade Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023046113A JP2023078376A (ja) | 2017-04-21 | 2023-03-23 | 遺伝子療法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1706410.6A GB201706410D0 (en) | 2017-04-21 | 2017-04-21 | Type 1 interferon gene therapy |
| GB1706410.6 | 2017-04-21 | ||
| GBGB1801511.5A GB201801511D0 (en) | 2018-01-30 | 2018-01-30 | Gene therapy |
| GB1801511.5 | 2018-01-30 | ||
| PCT/EP2018/060238 WO2018193119A1 (en) | 2017-04-21 | 2018-04-20 | Gene therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023046113A Division JP2023078376A (ja) | 2017-04-21 | 2023-03-23 | 遺伝子療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020517261A JP2020517261A (ja) | 2020-06-18 |
| JP2020517261A5 true JP2020517261A5 (cg-RX-API-DMAC7.html) | 2021-06-10 |
| JP7252135B2 JP7252135B2 (ja) | 2023-04-04 |
Family
ID=62165525
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019556929A Active JP7252135B2 (ja) | 2017-04-21 | 2018-04-20 | 遺伝子療法 |
| JP2023046113A Pending JP2023078376A (ja) | 2017-04-21 | 2023-03-23 | 遺伝子療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023046113A Pending JP2023078376A (ja) | 2017-04-21 | 2023-03-23 | 遺伝子療法 |
Country Status (23)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3128871A1 (en) * | 2019-02-09 | 2020-08-13 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Genetically modified hematopoietic stem and progenitor cells (hspcs) and mesenchymal cells as a platform to reduce or prevent metastasis, treat autoimmune and inflammatory disorders, and rebalance the immune milieu_and dysregulated niches |
| WO2020170215A1 (en) * | 2019-02-22 | 2020-08-27 | Oncolytics Biotech Inc. | T cell repertoire dynamics and oncolytic viral therapy |
| US20220362304A1 (en) * | 2019-03-20 | 2022-11-17 | 2Seventy Bio, Inc. | Adoptive cell therapy |
| CN112280829B (zh) * | 2020-04-07 | 2023-12-26 | 南方科技大学 | 一种试剂盒、样本标记方法、单细胞测序方法 |
| JP2023525720A (ja) * | 2020-05-11 | 2023-06-19 | アビタス バイオ インコーポレイティッド | Ｉｎ ｖｉｖｏ形質導入のためのベクター及び方法 |
| GB202007169D0 (en) * | 2020-05-14 | 2020-07-01 | Ospedale San Raffaele Srl | Epidermal growth factor receptor |
| IL298693A (en) * | 2020-06-04 | 2023-02-01 | Carisma Therapeutics Inc | New structures for chimeric antigen receptors |
| CN114426953A (zh) * | 2020-10-29 | 2022-05-03 | 未来智人再生医学研究院(广州)有限公司 | 一种表达il-12的多能干细胞衍生物及应用 |
| WO2022095642A1 (zh) * | 2020-11-03 | 2022-05-12 | 广州辑因医疗科技有限公司 | 细胞制剂、蛋白在表征造血干细胞中的用途及判定造血干细胞的方法 |
| CN114807155A (zh) * | 2021-01-18 | 2022-07-29 | 华东师范大学 | 用于基因编辑的组合物及其应用 |
| WO2024068617A1 (en) * | 2022-09-26 | 2024-04-04 | Institut Curie | Myeloid cells expressing il-2 and uses thereof for quick anticancer therapy |
| WO2024166936A1 (ja) * | 2023-02-08 | 2024-08-15 | 国立大学法人九州大学 | 腫瘍組織内においてｍ２マクロファージに分化することができ、ｍ２マクロファージに分化すると炎症性サイトカインを発現する細胞、および当該細胞を含む組成物 |
| WO2024194223A2 (en) * | 2023-03-17 | 2024-09-26 | Ospedale San Raffaele S.R.L. | Gene therapy |
| WO2025217427A1 (en) * | 2024-04-11 | 2025-10-16 | Genenta Science S.P.A. | Combination immunotherapy of solid cancers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9803351D0 (en) * | 1998-02-17 | 1998-04-15 | Oxford Biomedica Ltd | Anti-viral vectors |
| GB0009760D0 (en) | 2000-04-19 | 2000-06-07 | Oxford Biomedica Ltd | Method |
| US8389282B2 (en) * | 2007-03-30 | 2013-03-05 | Memorial Sloan-Kettering Cancer Center | Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes |
| KR101793615B1 (ko) * | 2009-04-30 | 2017-11-03 | 오스페달레 산 라파엘 에스.알.엘. | 유전자 벡터 |
| EP3434774A1 (en) * | 2013-01-17 | 2019-01-30 | ModernaTX, Inc. | Signal-sensor polynucleotides for the alteration of cellular phenotypes |
| US10562952B2 (en) * | 2015-09-10 | 2020-02-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-CD276 chimeric antigen receptors |
| SG10202109655VA (en) * | 2015-12-04 | 2021-10-28 | Novartis Ag | Compositions and methods for immunooncology |
-
2018
- 2018-04-20 PL PL18724470.2T patent/PL3612624T3/pl unknown
- 2018-04-20 DK DK18724470.2T patent/DK3612624T3/da active
- 2018-04-20 HR HRP20241603TT patent/HRP20241603T1/hr unknown
- 2018-04-20 EP EP18724470.2A patent/EP3612624B1/en active Active
- 2018-04-20 PT PT187244702T patent/PT3612624T/pt unknown
- 2018-04-20 ES ES18724470T patent/ES2995785T3/es active Active
- 2018-04-20 AU AU2018253959A patent/AU2018253959B2/en active Active
- 2018-04-20 BR BR112019021953-6A patent/BR112019021953A2/pt unknown
- 2018-04-20 FI FIEP18724470.2T patent/FI3612624T3/fi active
- 2018-04-20 LT LTEPPCT/EP2018/060238T patent/LT3612624T/lt unknown
- 2018-04-20 SG SG11201909814W patent/SG11201909814WA/en unknown
- 2018-04-20 SI SI201831181T patent/SI3612624T1/sl unknown
- 2018-04-20 US US16/604,484 patent/US20200078408A1/en active Pending
- 2018-04-20 CA CA3060145A patent/CA3060145A1/en active Pending
- 2018-04-20 IL IL270028A patent/IL270028B2/en unknown
- 2018-04-20 KR KR1020197034111A patent/KR102733541B1/ko active Active
- 2018-04-20 EP EP24202037.8A patent/EP4491233A3/en active Pending
- 2018-04-20 RS RS20241344A patent/RS66264B1/sr unknown
- 2018-04-20 HU HUE18724470A patent/HUE069690T2/hu unknown
- 2018-04-20 IL IL320674A patent/IL320674A/en unknown
- 2018-04-20 JP JP2019556929A patent/JP7252135B2/ja active Active
- 2018-04-20 WO PCT/EP2018/060238 patent/WO2018193119A1/en not_active Ceased
- 2018-04-20 CN CN201880040639.9A patent/CN110785488A/zh active Pending
- 2018-04-20 SM SM20240506T patent/SMT202400506T1/it unknown
-
2019
- 2019-10-21 MX MX2024012024A patent/MX2024012024A/es unknown
- 2019-10-21 MX MX2024012023A patent/MX2024012023A/es unknown
-
2023
- 2023-03-23 JP JP2023046113A patent/JP2023078376A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020517261A5 (cg-RX-API-DMAC7.html) | ||
| US20220204628A1 (en) | Compositions and methods for targeted immunomodulatory antibodies and fusion proteins | |
| Helmy et al. | Cancer immunotherapy: accomplishments to date and future promise | |
| Marin-Acevedo et al. | Cancer immunotherapy beyond immune checkpoint inhibitors | |
| Yousefi et al. | Immunotherapy of cancers comes of age | |
| Maus et al. | Making better chimeric antigen receptors for adoptive T-cell therapy | |
| Dotti et al. | Design and development of therapies using chimeric antigen receptor‐expressing T cells | |
| Baxevanis et al. | Cancer immunotherapy | |
| Houot et al. | T-cell–based immunotherapy: adoptive cell transfer and checkpoint inhibition | |
| AU2014225788B2 (en) | Engager cells for immunotherapy | |
| Lin et al. | Cellular immunotherapy for malignant gliomas | |
| HRP20241603T1 (hr) | Genska terapija | |
| WO2020224605A1 (zh) | 靶向bcma的工程化免疫细胞及其用途 | |
| US11229668B2 (en) | Maximizing T-cell memory and compositions and methods therefor | |
| AU2019387566A1 (en) | Chimeric antigen receptor factories and methods of use thereof | |
| US20230398216A1 (en) | Chimeric activation receptors | |
| Hinrichs | Molecular pathways: breaking the epithelial cancer barrier for chimeric antigen receptor and T-cell receptor gene therapy | |
| Shirjang et al. | Promising immunotherapy: Highlighting cytokine‐induced killer cells | |
| Xu et al. | Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer | |
| Azizi et al. | T-cell receptor and chimeric antigen receptor in solid cancers: current landscape, preclinical data and insight into future developments | |
| Knight et al. | Beyond immune checkpoint inhibitors: emerging targets in melanoma therapy | |
| Nardo et al. | Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors | |
| Yu et al. | CAR NK cell therapy for solid tumors: Potential and challenges | |
| Kucharczyk et al. | Adoptive T-Cell Therapy in Sarcomas | |
| US20240148867A1 (en) | Methods of treating cancer with a combination of adoptive cell therapy and a targeted immunocytokine |